Bio + AI Convergence: Synthetic Biology, Generative Drug Design & Programmable Cells
Biology became programmable in 2025. AI synthetic biology hit $94.73M, growing to $438M by 2034. Unilever ships bio-cleaners, BASF invests €600M annually. Companies reprogram cells for rocket fuel, materials. Master this convergence or face obsolescence.
